CNO Financial Group, Inc.
NYSE:CNOInsurance - Life
+$0.03 today
- Market cap
- $5.14B
- Beta
- 0.84
- P/E (TTM)
- 19.6
- EPS (TTM)
- $2.61
- Dividend yield
- 1.35%
Volume 0.67M
Average 0.71M
CNO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
CNO Financial Group, Inc.NYSE: CNO
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $299.1M rose 16.9% year over year, ahead of the -1.6% change in trailing-twelve-month EBITDA. Sequentially, it rose 63.7% from the prior quarter. Over 3 fiscal years it compounded at -11.2% a year.
Context
- EBITDA amounted to 18.8% of revenue in FY2025, down 5.2 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $945.68M (+12.2%) for the fiscal year ending Dec 2026, a step up from the -20.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $299.1M+63.7% QoQ
- Last fiscal yearDec 2025
- $842.8M-20.9% YoY
- LTMJun 2026
- $901.1M-1.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +16.9% | +23.3% | +6.4 pp |
| 1 year | -20.9% | +12.2% | +33.1 pp |
| 3-year CAGR | -11.2% | +1.6% | +12.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 842.8M USD
- Year-over-year change
- -20.9%
- 4-year CAGR
- -5.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 842.8M | -20.9% |
| FY2024 | 2024-12-31 | 1.07B | +23.4% |
| FY2023 | 2023-12-31 | 862.8M | -28.2% |
| FY2022 | 2022-12-31 | 1.2B | +12.9% |
| FY2021 | 2021-12-31 | 1.07B | — |
EBITDA vs competitors
How CNO compares with its peers on the latest reported figures
- CNO's LTM Jun 2026 EBITDA of $901.1M is the 3rd highest of the 9 companies compared; the peer median is $631.84M.
- Its year-over-year change of -1.6% is the 6th highest of 9, against a peer median of +14.3%.
- EBITDA amounts to 19.4% of revenue for CNO, versus a peer median of 33.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.39B | +17.8% | +0.2% | 23.2% | |
| LTM Sep 2026 | $946M | -27.8% | -49.6% | 17.4% | |
| LTM Jun 2026 | $901.1M | -1.6% | -11.2% | 19.4% | |
| LTM Sep 2026 | $723.53M | +62.4% | +1.3% | 36.7% | |
| LTM Jun 2026 | $672M | +17.1% | -24.6% | 9.6% | |
| LTM Jun 2026 | $591.68M | +11.6% | +10.6% | 30.5% | |
| LTM Sep 2026 | $423.79M | +33.1% | +3.5% | 40.3% | |
| LTM Sep 2026 | $413M | -33.1% | +46.3% | 46.7% | |
| LTM Sep 2026 | $387.22M | -35.1% | -6.5% | 58.0% | |
| Peer median (excluding CNO) | $631.84M | +14.3% | +0.7% | 33.6% | |
Competitors are the stored peer set for CNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.12B | 3.58B | 4.15B | 4.45B | 4.49B |
| Cost of Revenue | 2.42B | 1.79B | 2.61B | 2.74B | 2.48B |
| Gross Profit | 1.7B | 1.79B | 1.53B | 1.7B | 2.01B |
| Gross Margin | 41.2% | 50.1% | 37.0% | 38.3% | 44.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 267.9M | 287.9M | 290.9M | 304.5M | 0 |
| Operating Expenses | 966.3M | 973.7M | 1.18B | 1.18B | 1.72B |
| Depreciation & Amortization | 236.6M | 248.5M | 267.4M | 292.4M | 318.5M |
| EBITDA | 1.07B | 1.2B | 862.8M | 1.07B | 842.8M |
| EBITDA Margin | 25.8% | 33.6% | 20.8% | 24.0% | 18.8% |
| Operating Income | 733.1M | 816.5M | 356.8M | 518.3M | 293.4M |
| Operating Margin | 17.8% | 22.8% | 8.6% | 11.7% | 6.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.4M | 137M | 238.6M | 254.4M | 230.9M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 733.1M | 816.5M | 356.8M | 518.3M | 293.4M |
| Pre-Tax Margin | 17.8% | 22.8% | 8.6% | 11.7% | 6.5% |
| Income Tax Expense | 162.8M | 185.9M | 80.3M | 114.3M | 64.1M |
| Net Income | 570.3M | 630.6M | 276.5M | 404M | 229.3M |
| Net Margin | 13.8% | 17.6% | 6.7% | 9.1% | 5.1% |
| EPS (Basic) | 3.43 | 5.45 | 2.44 | 3.81 | 2.35 |
| EPS (Diluted) | 3.36 | 5.36 | 2.40 | 3.74 | 2.35 |
| Weighted Avg Shares | 128.4M | 117.65M | 113.28M | 106.14M | 97.76M |
| Weighted Avg Shares (Diluted) | 131.13M | 117.72M | 115.12M | 108.12M | 97.76M |
CNO Financial Group, Inc.
NYSE:CNO
Intrinsic Alpha fair value
Locked
Current Price
$56.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.